@sanofi Sanofi

Sanofi posts on X about sanofi, $san, paris, $sny the most. They currently have [-------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

[--] Week [-----] +98%
[--] Month [------] +33%
[--] Months [------] +161%
[--] Year [------] +2.60%

Mentions: [--] #

[--] Week [--] +129%
[--] Month [--] +36%
[--] Months [--] +150%
[--] Year [--] +11%

Followers: [-------] #

[--] Week [-------] +0.01%
[--] Month [-------] -0.04%
[--] Months [-------] -1.90%
[--] Year [-------] -2.60%

CreatorRank: [---------] #

Social Influence

Social category influence stocks 44.78% countries 11.94% cryptocurrencies 10.45% travel destinations 7.46% finance 4.48% technology brands 0.75% currencies 0.75%

Social topic influence sanofi #14, $san 10.45%, paris 6.72%, $sny 5.97%, copd 5.97%, japan 3.73%, acquisition 2.99%, health 2.99%, the first 2.99%, in the 2.99%

Top accounts mentioned or mentioned by @regeneron @usfda @paris2024 @eucommission @dynavaxcorp @emanews @fda @yaireinhorn @asmadual @attogladys @etpharma @realtalkms_jon @sedisa_net @drlovetruth @mhlwitteren @easdnews @openaito @blueprintmeds @europawire @bircancetin5

Top assets mentioned Sanofi (SNY) Santiment Network Token (SAN) Synthetify (SNY)

Top Social Posts

Top posts by engagements in the last [--] hours

"We're pleased to announce that we have completed the acquisition of @DynavaxCorp This strengthens our presence in adult immunization by bringing together Dynavax's vaccines with Sanofi's commercial reach global scale and development capabilities. Read our press release ➡ http://spkl.io/6016AtMRM http://spkl.io/6016AtMRM"
X Link 2026-02-10T14:11Z 146K followers, [----] engagements

"Were acquiring Vigil Neuroscience adding a potential first-in-class neuroinflammation treatment to our R&D pipeline. A Phase [--] Alzheimers study is plannedbecause patients urgently need new options. Learn more"
X Link 2025-05-22T09:55Z 146K followers, [----] engagements

"The Ministry of Health Labour and Welfare in Japan has approved our medicine for the treatment of certain children aged [--] to [--] years with asthma. Read our release: CC: @Regeneron http://spkl.io/6018AY3Xe http://spkl.io/6018AY3Xe"
X Link 2025-12-23T06:07Z 146K followers, [----] engagements

"#NEWS: The @EU_Commission has approved the first BTK inhibitor to treat adults with immune thrombocytopenia (#ITP) who are refractory to other treatments. Learn more: http://spkl.io/6012AYTR0 http://spkl.io/6012AYTR0"
X Link 2025-12-23T14:15Z 146K followers, [----] engagements

"Update on the @FDA review of our investigational treatment in non-relapsing secondary progressive multiple sclerosis (nrSPMS). Read our press release: https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-24-06-00-00-3210238 https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-24-06-00-00-3210238"
X Link 2025-12-24T06:06Z 146K followers, [----] engagements

"#NEWS: We've entered into an agreement to acquire @DynavaxCorp adding an adult hepatitis B vaccine and shingles candidate to our adult #vaccine portfolio and pipeline. Learn https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-24-06-15-00-3210241utm_source=X_global&utm_medium=Social&utm_campaign=VAX_2025_Dynavax+PR https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-24-06-15-00-3210241utm_source=X_global&utm_medium=Social&utm_campaign=VAX_2025_Dynavax+PR"
X Link 2025-12-24T07:12Z 146K followers, [----] engagements

"The @US_FDA accepted for Priority Review our sBLA for children between one and eight years of age with stage [--] #Type1Diabetes. Learn more about this milestone ➡ http://spkl.io/6017AmEPt http://spkl.io/6017AmEPt"
X Link 2026-01-05T06:07Z 146K followers, [----] engagements

"#NEWS: The @EU_Commission has approved our medicine to delay the onset of stage [--] type [--] diabetes in patients aged eight years and older with stage [--] #T1D marking the first disease-modifying treatment option in the EU for early T1D. Learn more: http://spkl.io/6010AWkLy http://spkl.io/6010AWkLy"
X Link 2026-01-12T06:15Z 146K followers, [----] engagements

"#NEWS: New data confirms potential in #AtopicDermatitis These results demonstrate the potential of OX40-ligand as an important #NEW mechanism in #AD. Learn more: #Dermatology #ClinicalResearch #Innovation http://spkl.io/6012AUQKa http://spkl.io/6012AUQKa"
X Link 2026-01-23T07:18Z 146K followers, [----] engagements

"Our Q4 and full-year [----] results are now available. Learn more: #SanofiResults $SAN $SNY http://spkl.io/6016AqNnO http://spkl.io/6016AqNnO"
X Link 2026-01-29T07:30Z 146K followers, [----] engagements

"The @EMA_News CHMP has recommended the approval of our therapy to treat patients aged 12+ with chronic graft-vs-host disease cGVHD a life-threatening complication that affects up to [--] in [--] people who undergo a stem cell transplant. Learn more ➡ http://spkl.io/6013ASKDU http://spkl.io/6013ASKDU"
X Link 2026-01-30T12:15Z 146K followers, [---] engagements

"New results from two phase [--] studies of our investigational oral therapy in type [--] Gaucher disease and Fabry disease are now available. Learn more about this #RareDisease research. https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-02-06-00-00-3229947 https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-02-06-00-00-3229947"
X Link 2026-02-02T06:07Z 146K followers, [----] engagements

"Our investigational BTK inhibitor for the potential treatment of wAIHA was granted Breakthrough Therapy Designation by @US_FDA and Orphan Drug by @MHLWitter_en in Japan validating our commitment to helping address unmet needs for people living with rare diseases. Learn more: https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-09-06-00-00-3234232 https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-09-06-00-00-3234232"
X Link 2026-02-09T06:07Z 146K followers, [----] engagements

"New NIRSE-GAL study published in The Lancet Infectious Diseases and presented at Respiratory Syncytial Virus (#RSV) Vaccine for the World conference shows public health outcomes with an infant RSV immunization program across two seasons. Read our press release ➡ http://spkl.io/6014AQJZm http://spkl.io/6014AQJZm"
X Link 2026-02-16T07:52Z 146K followers, [---] engagements

"What does Respiratory Syncytial Virus (#RSV) mean to you We recently worked with @NickChaffe to create a giant doodle installation based on our discussions with Healthcare Professionals (HCPs) about RSV. Watch the video to find out what they said"
X Link 2023-08-22T12:02Z 151.9K followers, [----] engagements

"As a proud global partner of @UN Secretary-General Special Envoy for #RoadSafety we #MakeASafetyStatement by signing the Responsibility Pledge at events hosted across the world. Recently we were happy to welcome @JeanTodt in Brazil to introduce the Pledge to Sanofians"
X Link 2023-09-20T14:30Z 152K followers, [----] engagements

"Were live from Hamburg gearing up for #EASD2023 Being part of the largest European scientific meeting in #diabetes is always a treat. If youre attending this years @EASDNews 59th Annual Meeting join us at our booth symposia and scientific presentations"
X Link 2023-10-01T13:00Z 151.9K followers, [----] engagements

"We aim to be an industry-leading company in Immunology. We are announcing today that we have entered into a collaboration with Teva to strengthen our commitment to advancing innovative treatment options for inflammatory conditions"
X Link 2023-10-04T15:00Z 151.9K followers, [----] engagements

"Learn more about our latest data in #Pompe disease across a wide range of patient characteristics and clinical circumstances at this years @WorldMuscleSoc. #WMS2023"
X Link 2023-10-06T06:20Z 151.1K followers, [----] engagements

"Young people will change the world. So today at @OneYoungWorld Sanofi NextGen Scholars Chaima Krystal and Dominick will join our #AMillionConversations Workshop to explore how we can build a more inclusive healthcare system. #OYW23"
X Link 2023-10-06T08:20Z 151.8K followers, [----] engagements

"Were proud to announce the first shipments of our Impact brand medicines have arrived in the Republic of Djibouti and are en route to Tanzania marking a significant step in our work to address healthcare access and inequity globally. Read more #ActWithImpact"
X Link 2023-10-19T12:27Z 151.9K followers, [----] engagements

"Thank you @ispad_org for hosting us in Rotterdam As the meeting comes to an end we are grateful to everyone who joined our scientific activities. We are already looking forward to the 50th Annual Conference in Lisbon Portugal. #SeeYouThere #ISPAD2023 #ISPAD2024"
X Link 2023-10-21T14:10Z 151.8K followers, [----] engagements

"👶 Are all infants at risk from Respiratory Syncytial Virus #RSV"
X Link 2023-10-30T13:02Z 151.9K followers, 1M engagements

"The @IntDiabetesFed estimates [---] million people living with #diabetes are undiagnosed. On #WorldDiabetesDay take the IDF risk assessment to know your risk of developing type [--] diabetes & know your response.Visit to take the test today #WDDKnowYourRisk"
X Link 2023-11-14T09:00Z 151.9K followers, [----] engagements

"@youmakemewow Hi @youmakemewow we take product complaints seriously and have reported your concern to our product quality team. Could you DM us with your contact details so they can reach out for more info If you have other health-related questions please talk to your healthcare provider"
X Link 2024-01-05T20:00Z 151.9K followers, [--] engagements

"And just like that its finally here2024 Were kicking off the new year with highlights from [----] of our partnership with the Olympic and Paralympic Games Paris [----] 👀"
X Link 2024-01-06T13:00Z 151.6K followers, [----] engagements

"Our CEO Paul Hudson joined @SquawkCNBC today in @Davos to highlight how we are using our #AI at-scale ambition to advance science for patients. #WEF24 "We could have ahead of us a golden generation of science born out of AI" says @Sanofi CEO Paul Hudson. https://t.co/n2Eqfr44iP "We could have ahead of us a golden generation of science born out of AI" says @Sanofi CEO Paul Hudson. https://t.co/n2Eqfr44iP"
X Link 2024-01-18T14:04Z 152K followers, [----] engagements

"Together were leading the science relay 🔥 Were proud to partner with the Paris [----] Olympic and Paralympic Torch Relays symbolizing unity and the pursuit of excellence. #IgnitingPotential #Paris2024"
X Link 2024-01-24T13:00Z 151.9K followers, [----] engagements

"Our Q4 [----] Financial Results are now available. Read the press release: #SanofiResults $SAN $SNY http://spkl.io/60144vC1m http://spkl.io/60144vC1m"
X Link 2024-02-01T08:00Z 151.5K followers, [----] engagements

"Our CEO Paul Hudson reflects on how we begin the year as a development-driven science-led tech-powered biopharma company: #SanofiResults $SAN $SNY http://spkl.io/60144vCGG http://spkl.io/60144vCGG"
X Link 2024-02-01T11:00Z 151.5K followers, [----] engagements

"Time to Play it Back Discover last month's highlights of our partnership with the Olympic and Paralympic Games @Paris2024. Ready for a glimpse of January 🔥 #IgnitingPotential #Paris2024"
X Link 2024-02-08T13:00Z 149.3K followers, [----] engagements

"200 days until the @Paris2024 Paralympic Games As para-athletes are gearing up to fly their countrys flag a new flag will also be flying: the #MeningitisFlag to unite the world in the fight against #meningitis. Watch Vaskanges amazing video to learn more 👇 💛💙💜"
X Link 2024-02-10T13:00Z 151.9K followers, [----] engagements

"#NEWS: Were presenting late-breaking Phase [--] data for a novel investigational oral BTK inhibitor in chronic spontaneous urticaria at#AAAAI24. Learn more:"
X Link 2024-02-24T15:09Z 151.9K followers, [----] engagements

"@chavezxyz Hi @chavezxyz we take adverse events seriously and have reported your concern to our Pharmacovigilance team. Could you send us a DM with your contact details so they can reach out for more info If you have other health-related questions please talk to your healthcare provider"
X Link 2024-03-05T21:41Z 151.9K followers, [--] engagements

"Were thrilled to announce that @sanofi has been named to @FastCompany's Most Innovative Companies of [----] Read more about this years #FCMostInnovative"
X Link 2024-03-19T17:00Z 151.8K followers, [----] engagements

"Were one team working in relay for one purposeevery single day. We chase the miracles of science to improve peoples lives. Learn how we turn the impossible into possible: #Sanofi #WeNeverSettle http://spkl.io/60134LAH7 http://spkl.io/60134LAH7"
X Link 2024-03-27T13:00Z 151.7K followers, [----] engagements

"Our CEO Paul Hudson reflects on our strong start of the year driven by launches and the transformation of our portfolio of medicines and vaccines. Learn more about our first quarter [----] results: #SanofiResults $SAN $SNY http://spkl.io/601542oaR http://spkl.io/601542oaR"
X Link 2024-04-25T10:00Z 151.6K followers, [----] engagements

"At #ATS2024 were presenting [--] abstracts across respiratory diseases including #COPD and #asthma. Were committed to further understanding patient needs in these complex conditions. Learn more https://bit.ly/3xLx9Jh https://bit.ly/3xLx9Jh"
X Link 2024-04-29T11:59Z 151.6K followers, [----] engagements

"Watching the Olympic torch arrive from Greece was such an inspiring moment for our Sanofians 🔥 We're excited to continue the torch relay tomorrow in @marseille for this once in a lifetime event. #Paris2024 #IgnitingPotential"
X Link 2024-05-08T21:00Z 151.6K followers, [----] engagements

"The Olympic Flame just passed through our R&D site in Montpellier France 🔥 The journey is not over the relay goes on with lots of key stops coming up. Stay tuned ✨ #IgnitingPotential #Paris2024 @Paris2024"
X Link 2024-05-15T06:27Z 151.6K followers, [----] engagements

"#NEWS: Late-breaking data from our replicate Phase [--] trial in COPD were presented at #ATS2024 and published in @NEJM. Explore the latest results for this complex respiratory disease. @Regeneron Read our press release: http://spkl.io/601144bCN http://spkl.io/601144bCN"
X Link 2024-05-20T18:36Z 151.6K followers, [----] engagements

"Today hours from the opening of #VivaTech were excited to announce our collaboration with @Formation Bio & @OpenAI to build first-in-class AI-powered software. Join us at VivaTech for more on our AI innovations"
X Link 2024-05-21T12:05Z 151.6K followers, [---] engagements

"Today hours from the opening of #VivaTech were excited to announce our collaboration with @FormationBio & @OpenAI to build first-in-class AI-powered software. Join us at VivaTech for more on our AI innovations"
X Link 2024-05-21T12:49Z 151.6K followers, [----] engagements

"#NEWS: Data from a Phase 2b study for a novel investigational oral BTK inhibitor for the treatment of asthma were presented at #ATS2024. Learn more 👇"
X Link 2024-05-22T17:27Z 151.6K followers, [----] engagements

"@kataypasifik Hi@kataypasifikwe take adverse events seriously and have reported your concern to our Pharmacovigilance team.Could you send us a DM with your contact details so they can reach out for more infoIf you have other health-related questions please talk to your healthcare provider"
X Link 2024-05-23T12:19Z 151.6K followers, [--] engagements

"#NEWS update on the @FDA priority review of our investigational medicine for certain adults living with uncontrolled COPD. Read our press release 👇 @Regeneron"
X Link 2024-05-31T05:08Z 151.6K followers, [----] engagements

"#NEWS: The CHMP has recommended the approval of our #COPD medicine paving the way for a new treatment option for adults with uncontrolled COPD with raised blood eosinophils in the European Union. Read more about the latest news 👇 @Regeneron"
X Link 2024-05-31T05:27Z 151.6K followers, [----] engagements

"The Sanofi Cup Final was legendary Almost [---] Sanofi athletes from across the world. [--] teams. [--] sports. And as One Sanofi we came together to channel the spirit of the Olympic and Paralympic Games Paris 2024: our determination and teamwork taking center stage 💪"
X Link 2024-06-06T09:40Z 151.6K followers, [----] engagements

"Meet Amber one of our inspiring women making a difference at Sanofi. ✨ Leading our Gender+ WISE ERG program in North America she empowers her colleagues to build the skills they need to grow and develop professionally. Discover her story 👇 #InspireInclusion #WomenInTech"
X Link 2024-06-14T10:00Z 151.6K followers, [----] engagements

"Thats a wrap on the Sanofi Cup Final More than just a competition this was the first time weve gathered thousands of Sanofians from around the world to explore what science and sports have in common. 🔥 #Paris2024 #IgnitingPotential #WeNeverSettle @Paris2024"
X Link 2024-06-17T15:00Z 151.7K followers, [----] engagements

"Want a #BTS look into the Olympic Torch Relay 🔥 We captured all the most incredible moments from when the #Olympic Flame stopped by our site in Neuville-sur-Sane France 🙌 #IgnitingPotential #Paris2024 #WeNeverSettle @paris2024"
X Link 2024-06-28T12:01Z 151.6K followers, [----] engagements

"The @EU_Commission approved our medicine for adults with uncontrolled #COPD. As the first-ever targeted therapy for COPD this treatment offers new hope for those who previously had little options for this burdensome disease in the EU ➡ CC: @Regeneron http://spkl.io/601047kHm http://spkl.io/601047kHm"
X Link 2024-07-03T06:20Z 151.6K followers, [---] engagements

"The @EU_Commission approved our medicine for adults with uncontrolled #COPD. As the first-ever targeted therapy for COPD this treatment offers new hope for those who previously had little options for this burdensome disease in the EU. CC: @Regeneron Learn more"
X Link 2024-07-03T09:24Z 151.6K followers, [----] engagements

"Its more important than ever to ensure that #AI is designed and developed to minimize bias. For us tech doesn't work unless it works for everyone. Read more: http://spkl.io/601347nDb http://spkl.io/601347nDb"
X Link 2024-07-05T12:00Z 151.6K followers, [----] engagements

"Whether in sports or in science were as committed as the team of people who stand behind us. 🤝💪 Ask #TeamSanofi member Ezra Frech and Youxin Kong a Sanofi senior scientist and volunteer for the Olympic Games #Paris2024"
X Link 2024-07-10T12:20Z 151.6K followers, [----] engagements

"For #TeamSanofi athlete @BubucheOfficiel and Arnaud Dourlens our first torchbearer for the Olympic Torch Relay Paris [----] their supporters make sure they never settle when it comes to their success 🌟🤝 #IgnitingPotential #WeNeverSettle @Paris2024"
X Link 2024-07-16T15:00Z 151.6K followers, [----] engagements

"Our Q2 [----] results are now available. Learn more. #SanofiResults $SAN $SNY"
X Link 2024-07-25T06:45Z 151.5K followers, [----] engagements

"Week [--] of the Olympic Games Paris [----] ✅ Check out our highlights Spoiler there is a LOT 🥇 Stay tuned Were excited for the days ahead as our #TeamSanofi athletes Valriane Ayayi & Dany Dann compete. Go Team Sanofi 💜 @Paris2024"
X Link 2024-08-06T16:01Z 151.6K followers, [----] engagements

"That's a wrap for the Olympic Games Paris [----] 🤩 Our Team Sanofi dazzled us by winning [--] medals Also THANK YOU to the 1000+ Sanofians who volunteered during the Olympics 🫶 We're ready to cheer on our Team Sanofi at the Paris [----] #Paralympics Games #Olympics #Paris2024"
X Link 2024-08-12T16:00Z 151.2K followers, [----] engagements

"Week [--] of the Olympic Games Paris [----] is in the books 💜 💜 We're so proud of our #TeamSanofi Athletes Volunteers and Igniters for their dedication and hard work🥇 #WeNeverSettle #IgnitingPotential #Paris2024 @Paris2024"
X Link 2024-08-13T18:00Z 150.5K followers, [----] engagements

"At #ERSCongress were presenting [--] abstracts united by a singular goal: to advance care for people with immune-mediated respiratory diseases such as #COPD #asthma and #CRSwNP. Learn more about our presentations including select data in partnership with @Regeneron"
X Link 2024-08-26T05:42Z 151.2K followers, [----] engagements

"What a magical start ✨Here are the highlights 👇 🐎 Our Metal Horse from the #Paris2024 Olympic Games Opening Ceremony is now on display at the Paris mayors office. 🌍 Sanofi volunteers have traveled across the globe ringing in plenty of energy and motivation for a kick-off at the UNESCO House in Paris 🔥 The Paris [----] #ParalympicFlame made a stop at La Maison Sanofi with our CEO Paul Hudson & our EVP Corporate Affairs @DerveloyA proudly carrying it to our HQ. #Paralympics @paris2024"
X Link 2024-08-29T08:15Z 151.2K followers, [----] engagements

"#Paris2024 Paralympic Games was a blast Were so proud of our #TeamSanofi athletes and Sanofi volunteers for putting in the hard work every step of the way 🙌 #WeNeverSettle #IgnitingPotential #Paralympics @Paris2024"
X Link 2024-09-10T07:14Z 151.2K followers, [----] engagements

"Now that weve brought the #Paris2024 Paralympic Games to a close we want to say a huge thank you to our [----] volunteers that helped to make both the #Olympic and #Paralympic Games Paris [----] a reality 💜 🙌 #IgnitingPotential #WeNeverSettle @Paris2024"
X Link 2024-09-10T16:36Z 151.2K followers, [----] engagements

"#NEWS: Today the @US_FDA approved our #MultipleMyeloma combination therapy for certain adults who are newly diagnosed. Read more about the news"
X Link 2024-09-20T22:55Z 151.2K followers, [----] engagements

"Jane Pavlik is part of our #Manufacturing & #Supply teams. While turning R&D ideas into reality for patients comes with its challenges she believes that diversity brings fresh perspectives and enhances problem-solving. Learn more: http://spkl.io/6010fJibM http://spkl.io/6010fJibM"
X Link 2024-09-25T11:01Z 151.2K followers, [----] engagements

"@StewTeelee Hi @StewTeelee we take adverse events seriously and have reported your concern to our Pharmacovigilance team. Could you send us a DM with your contact details so they can reach out for more info If you have other health-related questions please talk to your healthcare provider"
X Link 2024-09-26T17:40Z 151.2K followers, [--] engagements

"Chinas National Medical Products Administration has approved our treatment for uncontrolled #COPD. With this approval we hope to address a major public health concern and help more people living with this progressive respiratory disease worldwide. For more👇 CC: @Regeneron"
X Link 2024-09-27T11:08Z 151.2K followers, [----] engagements

"The @US_FDA has approved our medicine as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. This marks the first-ever biologic approved for COPD. CC: @Regeneron"
X Link 2024-09-27T14:18Z 151.2K followers, [----] engagements

"#News: at #IDWeek2024 new real-world effectiveness data on our respiratory syncytial virus (#RSV) immunization for infants will be presented. Learn More"
X Link 2024-10-09T05:10Z 151.5K followers, [----] engagements

"Our Q3 [----] results are now available. Learn more. #SanofiResults $SAN $SNY"
X Link 2024-10-25T06:30Z 150.4K followers, [----] engagements

"Our CEO Paul Hudson reflects on our strong Q3 pushed forward by the momentum of our launches of innovative medicines and vaccines. Learn more: #SanofiResults $SAN $SNY http://spkl.io/6016fRCkY http://spkl.io/6016fRCkY"
X Link 2024-10-25T10:06Z 150.4K followers, [----] engagements

"#NEWS: The @US_FDA granted Breakthrough Therapy designation to our investigational treatment for non-relapsing secondary progressive #MultipleSclerosis an area of unmet need for the community. Read our press release ➡ http://spkl.io/6013fwxZD http://spkl.io/6013fwxZD"
X Link 2024-12-13T06:29Z 150.5K followers, [----] engagements

"The biopharma industry is entering a transformative era. In an article with the @wef our CEO Paul Hudson discusses four key areas that can power the progress of medicine [----]. Read more 👇 #WEF25 #WorldEconomicForum #Biopharma"
X Link 2025-01-16T16:00Z 150.1K followers, [----] engagements

"#NEWS: New data at #AAAAI25 reinforce our scientific leadership and commitment to innovation across immune-meditated diseases including #CSU #asthma and #COPD. Read about our presentations CC: @Regeneron"
X Link 2025-02-06T06:15Z 149.9K followers, [----] engagements

"#NEWS: Today marks an important step forward in #IBD research. Results from a phase 2b study presented at #ECCO25 demonstrate the potential of an investigational TL1A monoclonal antibody in patients with #UC and #CD. Read about our data. CC: @TevaPharm"
X Link 2025-02-22T07:40Z 149.7K followers, [----] engagements

"#NEWS: Today Japans Ministry of Health Labour and Welfare approved our combination regimen for patients with newly diagnosed #MultipleMyeloma. Learn more"
X Link 2025-02-25T06:14Z 149.7K followers, [----] engagements

"At #AAD2025 we shared late-breaking data from our pivotal trial in adults with #BullousPemphigoid. Learn more about the results presented with @Regeneron"
X Link 2025-03-08T18:08Z 149.7K followers, [----] engagements

"Were spotlighting #MyelomaMilestone moments to raise awareness and amplify the stories of the myeloma community. Learn more about how to get involved during Myeloma Action Month from @IMFmyeloma. What was a major #MyelomaMilestone moment for you Tell us in the comments Take action this #MyelomaACTIONMonth Tag and share with your circle and use the #MyelomaMilestone hashtag to spread knowledge of multiple myeloma. ❤ https://t.co/lsDHNj7lW3 What was a major #MyelomaMilestone moment for you Tell us in the comments Take action this #MyelomaACTIONMonth Tag and share with your circle and use the"
X Link 2025-03-11T13:00Z 149.7K followers, [----] engagements

"We announced entering into an agreement to acquire DR-0201 Dren Bios bispecific myeloid cell engager for deep B-cell depletion. The acquisition subject to closing conditions including receipt of regulatory approval will broaden our immunology pipeline"
X Link 2025-03-21T13:58Z 149.6K followers, [----] engagements

"Our first quarter [----] results are now available. Read the press release. #SanofiResults $SAN $SNY"
X Link 2025-04-24T06:30Z 149.2K followers, [----] engagements

"We announced an agreement to acquire Blueprint Medicines a biopharmaceutical company specializing in systemic mastocytosis a rare immunological disease and other KIT-driven diseases"
X Link 2025-06-02T05:21Z 148.9K followers, [----] engagements

"The @US_FDA approved our medicine as the first and only treatment specifically indicated for adults with #BullousPemphigoid (BP) a chronic and debilitating skin disease. Read more CC: @Regeneron"
X Link 2025-06-20T05:11Z 148.8K followers, [----] engagements

"#NEWS: The @EMA_News CHMP has recommended the approval of our combination therapy to treat people with newly diagnosed #MultipleMyeloma (MM) eligible for transplant. The decision represents a significant step for the MM community. Learn more"
X Link 2025-06-23T05:33Z 148.8K followers, [----] engagements

"The @US_FDA has granted Orphan Drug Designation to our investigational treatment for antibody-mediated rejection (AMR) in transplantation where no FDA-approved treatments are currently available. Learn more"
X Link 2025-06-25T13:27Z 148.8K followers, [----] engagements

"Weve ranked 10th overall and #1 in Pharma & Biotech on @TIMEs [----] list of the Worlds Most Sustainable Companies. Learn how were working to reduce environmental impact and strengthen resilience"
X Link 2025-06-27T16:02Z 148.8K followers, [----] engagements

"#NEWS: Sanofis investigational treatment for people living with chronic inflammatory demyelinating polyneuropathy (#CIDP) was granted orphan designation in Japan. Learn more"
X Link 2025-06-30T12:59Z 148.8K followers, [----] engagements

"#NEWS: Sanofis investigational treatment for people living with geographic atrophy due to age-related macular degeneration granted fast track designation in US. Learn more"
X Link 2025-07-17T13:22Z 148.8K followers, [----] engagements

"We have completed the acquisition of @BlueprintMeds expanding our portfolio in rare immunological disease and adding early-stage pipeline in immunology"
X Link 2025-07-18T11:55Z 148.8K followers, [----] engagements

"Our second quarter [----] results are now available. Read the press #SanofiResults $SAN $SNY https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2025 https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2025"
X Link 2025-07-31T06:38Z 148.9K followers, [----] engagements

"Our CEO Paul Hudson on Q2 2025: continued pipeline progress key approvals and milestones. Read more: #SanofiResults $SAN $SNY https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2025 https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2025"
X Link 2025-07-31T09:37Z 148.9K followers, [----] engagements

"The @EMA_News has granted Orphan Drug Designation to our investigational Brutons tyrosine kinase (BTK) inhibitor for IgG4-related disease (IgG4-RD) a rare immune-mediated disease that has no currently approved medicines. Learn more"
X Link 2025-08-14T14:34Z 148.9K followers, [----] engagements

"#NEWS: The @US_FDA has approved the first oral reversible Brutons tyrosine kinase (BTK) inhibitor for adults with persistent or chronic immune thrombocytopenia (#ITP). Learn more"
X Link 2025-09-02T15:03Z 148.9K followers, [----] engagements

"#NEWS: New data at #EADVCongress [----] underscores the potential of novel platforms and technologies across chronic inflammatory skin conditions including atopic dermatitis and hidradenitis suppurativa. Read about our data CC: @Regeneron"
X Link 2025-09-03T05:09Z 148.8K followers, [----] engagements

"#NEWS: Phase [--] study evaluating our investigational treatment in #AtopicDermatitis met its primary endpoints demonstrating potential as a new treatment option for people with moderate-to-severe disease. Learn more"
X Link 2025-09-04T05:15Z 148.9K followers, [----] engagements

"#NEWS: At #ERSCongress [----] were presenting new data across #Asthma #COPD and #CRSwNP reinforcing our breadth of innovation in chronic respiratory conditions and commitment to helping patients breathe better. Read about our data CC: @Regeneron"
X Link 2025-09-04T09:30Z 148.8K followers, [----] engagements

"The Chinese National Medical Products Administration (NMPA) has approved our disease-modifying therapy in autoimmune #T1D. Learn more"
X Link 2025-09-10T05:23Z 148.9K followers, [----] engagements

"#NEWS: At #ECTRIMS2025 were sharing new data in #MultipleSclerosis as we continue to test the bounds of clinical possibility across the spectrum of disease. Learn more about our MS research and innovation"
X Link 2025-09-10T06:04Z 148.8K followers, [----] engagements

"#NEWS: Sanofis investigational treatment for people living with neovascular or wet age-related macular degeneration granted fast track designation in US. Learn more"
X Link 2025-09-11T08:57Z 148.8K followers, [----] engagements

"#NEWS: At #EADVCongress [----] were presenting results from a phase 2a study evaluating our investigational therapy in moderate-to-severe #HidradenitisSuppurativa a chronic and debilitating inflammatory skin disease. Learn more about our data"
X Link 2025-09-17T05:06Z 148.8K followers, [----] engagements

"#NEWS update on the @FDA review of our investigational treatment in non-relapsing secondary progressive multiple sclerosis (nrSPMS)"
X Link 2025-09-22T05:14Z 148.8K followers, [----] engagements

"The @US_FDA has granted Fast Track designation to our investigational gene therapy for the treatment of #MyotonicDystrophyType [--] reinforcing our dedication to developing new medicines that address unmet needs for people living with #RareDiseases. Learn more"
X Link 2025-09-23T05:06Z 148.8K followers, [----] engagements

"Lithuania presidency of Euro Council C.Viehbacher speaks on panel with WHO Min Health Greece Lithuania and NGOs #healthforumLT"
X Link 2013-11-19T12:02Z 151.2K followers, [--] engagements

"#DYK sleeping sickness occurs in just [--] sub-Saharan African countries where 'tsetse flies' transmit the disease http://t.co/WAXSdfMD2F"
X Link 2015-03-05T11:05Z 151.1K followers, [--] engagements

"#BabySafetyMonth: We're fighting maternal & infant mortality in Cameroon http://t.co/TVNZlgto7T http://t.co/1eEZBwcAWx http://bit.ly/1grg5uq http://bit.ly/1grg5uq"
X Link 2015-09-16T18:00Z 151.2K followers, [--] engagements

"Tomorrow we will be live streaming our investor presentation on the $SNY financial results. Join us: http://bit.ly/2kDGOZ0 http://bit.ly/2kDGOZ0"
X Link 2017-02-07T16:03Z 151.2K followers, [--] engagements

"Our Annual [----] results announced today. For more info: $SNY http://bit.ly/2klTWkq http://bit.ly/2klTWkq"
X Link 2017-02-08T12:49Z 151.2K followers, [--] engagements

"We'll be commenting on our Q3 financial results on Thursday Nov. 2nd during a live webcast. Register here $SNY $SAN http://bit.ly/2gLPCuo http://bit.ly/2gLPCuo"
X Link 2017-10-30T14:45Z 151.2K followers, [--] engagements

"Our Q3 [----] results were announced today. For more info: $SNY #infographic #sanofi http://bit.ly/2gLPCuo http://bit.ly/2gLPCuo"
X Link 2017-11-02T06:36Z 151.2K followers, [--] engagements

"Our Q3 [----] financial results are announced today. Join the live webcast here: #Sanofi $SNY $SAN http://bit.ly/2gLPCuo http://bit.ly/2gLPCuo"
X Link 2017-11-02T09:49Z 151.2K followers, [--] engagements

"#Sanofi CEO Olivier Brandicourt comments on Q3 [----] financial results $SNY"
X Link 2017-11-02T13:53Z 151.2K followers, [--] engagements

"Our Q4 & Full Year [----] Results were announced today. For more info: $SNY #infographic #Sanofi http://bit.ly/2EIJ9M6 http://bit.ly/2EIJ9M6"
X Link 2018-02-07T06:46Z 151.2K followers, [--] engagements

"Reminder : Q4 & Full Year [----] Results will be streaming at 2:00 pm CET / 8:00 am ET. Last chance to register: $SAN http://bit.ly/2EIJ9M6 http://bit.ly/2EIJ9M6"
X Link 2018-02-07T09:00Z 151.2K followers, [--] engagements

"#EarthDay2018 Jean-Christophe Bligny our Global Head Environment on #Sanofi's commitment to the fight against #Climatechange in particular by reducing our carbon footprint: http://mediaroom.sanofi.com/climate-change-poses-a-health-crisi/ http://mediaroom.sanofi.com/climate-change-poses-a-health-crisi/"
X Link 2018-04-20T10:20Z 151.2K followers, [--] engagements

"New phase 2b maintenance results evaluating an investigational treatment for ulcerative colitis and Crohns disease highlighting our commitment to scientific innovation for patients with inflammatory bowel disease. Read our press release. https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-17-11-00-00-3239014 https://www.sanofi.com/en/media-room/press-releases/2026/2026-02-17-11-00-00-3239014"
X Link 2026-02-17T11:08Z 146K followers, [---] engagements

"GVHD is a serious complication affecting up to [--] in [--] patients who undergo a stem cell transplant. Today February [--] marks #GVHDDay - an opportunity to recognize and empower those living this devastating disease. Learn more ➡ #ProtectingThePromise #GVHD http://spkl.io/6018AQnpp http://spkl.io/6018AQnpp"
X Link 2026-02-17T06:30Z 146K followers, [---] engagements

"#NEWS: The National Medical Products Administration in China has approved treatments for obstructive hypertrophic cardiomyopathy (oHCM) and familial chylomicronaemia syndrome (FCS). Learn more ➡ http://spkl.io/6017AoHXz http://spkl.io/6017AoHXz"
X Link 2026-01-15T06:15Z 146K followers, [----] engagements

".@EMA_NEWS has granted orphan designation to our investigational therapy for AATD related emphysema validating our commitment to pursuing medicines for #RareDiseases with significant unmet medical need. Learn more ➡ http://spkl.io/6019Ac17d http://spkl.io/6019Ac17d"
X Link 2025-12-17T06:06Z 146K followers, [----] engagements

"#NEWS: Phase [--] update on our clinical study for primary progressive multiple sclerosis. Read our press release ➡ https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-15-06-05-00-3205094 https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-15-06-05-00-3205094"
X Link 2025-12-15T06:20Z 146K followers, [----] engagements

"#NEWS: Update on our phase [--] investigational medicine studying multiple sclerosis. Read our press release ➡ https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-15-06-00-00-3205091 https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-15-06-00-00-3205091"
X Link 2025-12-15T06:16Z 146K followers, [----] engagements

"#NEWS: The National Medical Products Administration in China has approved treatments for hemophilia A or B with or without inhibitors and acquired thrombotic thrombocytopenia purpura (aTTP). Learn more https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-11-06-00-00-3203611 https://www.sanofi.com/en/media-room/press-releases/2025/2025-12-11-06-00-00-3203611"
X Link 2025-12-11T15:39Z 146K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing